TP63 and neoplasm: Similarly, CRISPR-Cas9-mediated deletion of individual components of the TP63 SEs reduces its expression levels and restrains the proliferation of esophageal squamous cell carcinoma (ESCC) cells, unveiling the oncogenesis role of TP63 in tumor malignancy [208].